Dieu-Nosjean, Marie Caroline
Sorbonne Université,
France
2025 Rank: 52390
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 999 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52390 | 53543 |
| Total Cites | 1102 | 1152 |
| H-index | 18 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 5 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 162 | 166 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 493 | 514 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 799 | 821 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.40 |
| Self-Citation Percentage |
4.34%
|
|
Dieu-Nosjean, Marie Caroline
Inserm,
France
2024 Rank: 45169
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 919 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45169 | 51378 |
| Total Cites | 1151 | 1191 |
| H-index | 18 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 176 | 181 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 491 | 512 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 873 | 890 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.34 |
| Self-Citation Percentage |
3.36%
|
|
Dieu-Nosjean, Marie Caroline
Sorbonne Université,
France
2023 Rank: 60422
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1349 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60422 | 66234 |
| Total Cites | 1209 | 1269 |
| H-index | 18 | 19 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 153 | 157 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 416 | 439 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 960 | 993 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.28 |
| Self-Citation Percentage |
4.73%
|
|
Dieu-Nosjean, Marie Caroline
Sorbonne Universite,
France
2022 Rank: 71933
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1741 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71933 | 80722 |
| Total Cites | 1222 | 1276 |
| H-index | 19 | 20 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 176 | 181 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 451 | 469 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 952 | 978 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.30 |
| Self-Citation Percentage |
4.23%
|
|
Dieu-Nosjean, Marie Caroline
Sorbonne Universite,
France
2021 Rank: 89222
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1990 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89222 | 99132 |
| Total Cites | 1717 | 1829 |
| H-index | 22 | 23 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 242 | 254 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 622 | 656 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1338 | 1397 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.31 |
| Self-Citation Percentage |
6.12%
|
|
Dieu-Nosjean, Marie Caroline
Sorbonne Universite,
France
2020 Rank: 101547
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2051 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 101547 | 110791 |
| Total Cites | 1017 | 1113 |
| H-index | 19 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 128 | 141 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 330 | 365 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 806 | 856 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.30 |
| Self-Citation Percentage |
8.63%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.